Clinical Trials Browser

Phase 2/3 × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × Clear all

NCT03937544 2025-05-29

Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL

Phase 2/3 Recruiting

LymphoidOther hematologic neoplasm

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma